Results 151 to 160 of about 3,632 (212)
The cancer stem cell: Evidence for its origin as an injured autoreactive T Cell [PDF]
Peter Grandics
core +1 more source
Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer. [PDF]
BMC BiotechnolJi Y, Qin Y, Tan Q, Qiu Y, Han S, Qi X.
europepmc +1 more source
Perioperative treatment with tranexamic acid in melanoma (PRIME): protocol for a Danish multicentre randomised controlled trial investigating the prognostic and treatment-related impact of the plasminogen-plasmin pathway. [PDF]
BMJ OpenKristjansen KA +4 more
europepmc +1 more source
Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review. [PDF]
Front ImmunolLiao SQ +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
FIBRINOLYSIN AND HYALINE-MEMBRANE DISEASE
Lancet, The, 1961E J, TURNER, A G, STEWART
exaly +3 more sources
Fibrinolysin Treatment of Thromboembolism
JAMA - Journal of the American Medical Association, 1964Fibrinolysin (Thrombolysin) has been used in various dosage schedules for thromboembolic disorders, but its clinical value has not been established. In this study, a single large intravenous dose was given at onset of anticoagulant therapy to 170 patients with thrombophlebitis, pulmonary embolism, or acute myocardial infarction.
H L, ISRAEL +3 more
exaly +3 more sources
Enzymatic débridement with bovine fibrinolysin
The American Journal of Surgery, 1959Abstract Bovine fibrinolysin, alone or in combination with desoxyribonuclease, appears to be of value in the enzymatic debridement of ulcerating wounds. This agent achieved more rapid and frequently more effective superficial debridement of a significant proportion of ulcerating surfaces which had failed to respond satisfactorily to other forms of ...
W W, COON +3 more
openaire +2 more sources